BIIB wins FDA approval for Leqembi Iqlik, a fast, subcutaneous option for early Alzheimer's patients transitioning from IV infusions.

MGIC Investment gains from new business, solid annual persistency, higher levels of home sales, effective capital deployment, and sufficient liquidity.

POST to sell 8th Avenue's pasta business for $375 million while boosting share repurchases with a fresh $500 million authorization.

DORM, SMP and PLOW are set to benefit as aging U.S. vehicles drive soaring replacement parts demand.

NEW YORK , Sept. 1, 2025 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. (NASDAQ: ALT) between August 10, 2023 and June 25, 2025, both dates inclusive (the "Class Period"), of the important October 6, 2025 lead plaintiff deadline.

American importers are facing the highest average tariff rates in nearly 100 years following President Trump's India tariff bump, and businesses are quickly coming to terms with a difficult choice: take a margin hit from the added costs or pass the burden onto their customers.

WMT lifts its sales and EPS outlook as e-commerce and ads fuel growth, but liability costs and margin pressure keep profit recovery in focus.

Adam Horlock says the Cracker Barrel (CBRL) sell-off and subsequent rebound was about more than changing and unchanging the logo — it's about brand identity. He talks about where the company went wrong and the lessons Cracker Barrel can take away from the story that garnered national attention.

The gold market has cracked above the $3500 level in the futures market, showing signs that we are going even higher. However, the volume might have been a bit of a problem as well, as it is Labor Day in the United States.

The precious metal was racking up gains as investors weighed up fresh sources of uncertainty on Labor Day.

CRL joins EASYGEN to speed CAR-T therapy delivery, which may boost patient access and investor sentiment.

The oil markets continue to see a bit of consolidation, as we are likely to see a bit of noise due to the fact that it is Labor Day in the United States, and therefore volume will have been a bit lacking. However, this is a market that has been

BIO's strong ddPCR growth and solid diagnostics demand support its stock despite market pressures and stiff competition.

Marvell's meltdown has triggered its extremely rich rebound prospects, thanks to the double digits data center/enterprise sales growth during the ongoing AI boom. This is on top of the growing contracts/pipelines, significantly aided by the management's promising market share gains in the growing 2028 TAM. These reasons are also why we believe that MRVL offers a rare, deep-value buy opportunity for those still looking to tap into the multi-year cloud supercycle.

KTOS progresses in defense propulsion with GE Aerospace tie-up, new engine plant and rising demand for unmanned combat aircraft.

ITW shows segment gains and margin strength, but faces pressure from weak polymers, construction and high debt.

NEW YORK, Sept. 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Vera Bradley, Inc. (NASDAQ: VRA) resulting from allegations that Vera Bradley may have issued materially misleading business information to the investing public.

CoreWeave stock has dropped back, putting its deal for Core Scientific at risk. A renegotiation seems likely.

CIEN's fiscal Q3 results are likely to reflect surging cloud provider revenues, WaveLogic traction and growing Blue Planet adoption despite margin pressures.

In a week that saw the S&P 500 lose value, one stock in particular, space rocket operator Rocket Lab (RKLB 1.42%), glowed a bright shade of green as it rocketed to close the week 9.5% higher on Friday.